{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:30:59Z","timestamp":1790134259545,"version":"4.0.1"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Risk factors for venous thromboembolism (VTE) and their relative magnitudes across different phases of care in inflammatory bowel disease (IBD) are poorly understood. Therefore, we performed a systematic review to identify risk factors for VTE in patients with IBD during the hospitalized, post-operative, post-discharge, and ambulatory phases of care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>MEDLINE, EMBASE, and Cochrane CENTRAL were systematically searched from inception through to April 2024 without language restriction. We included studies that reported risk factors for VTE among adults with IBD. Summary estimates with 95% confidence intervals (CIs) were calculated for individual risk factors overall and stratified by phase of care using random effects models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 123 studies with over 23\u2005510\u2005969 patients were analyzed. We identified 48 variables for meta-analysis overall and 27 were significantly associated with VTE. The strongest risk factors were prior VTE (odds ratio [OR], 4.44; 95% CI, 2.63-7.49), surgical complications (OR, 3.06; 95% CI, 2.48-3.77), urgent surgery (OR, 2.33; 95% CI, 1.62-3.35), blood transfusions (OR, 2.68; 95% CI, 1.17-6.12), hypoalbuminemia (OR, 2.25; 95% CI, 1.93-2.62), and total parenteral nutrition (OR, 2.21; 95% CI, 1.85-2.64). Corticosteroids (OR, 1.60; 95% CI, 1.46-1.76) but not anti-tumor necrosis factor therapy (OR, 0.66; 95% CI, 0.46-0.97) were associated with an increased risk of VTE. No major differences were observed for most variables between hospitalized, post-operative, and post-discharge settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We identified multiple risk factors associated with VTE across different phases of care. This work will help in the development of future predictive models to guide thromboprophylaxis in IBD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ibd\/izaf078","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T08:28:37Z","timestamp":1743668917000},"page":"2286-2295","source":"Crossref","is-referenced-by-count":8,"title":["Risk Factors for Venous Thromboembolism in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis by Phase of Care"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5046-6064","authenticated-orcid":false,"given":"Michal","family":"Gozdzik","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology, University of Alberta , Edmonton, Alberta ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Unninayar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology, University of Ottawa , Ottawa, Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah M","family":"Siegal","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology, University of Ottawa , Ottawa, Ontario ,","place":["Canada"]},{"name":"Ottawa Hospital Research Institute, The Ottawa Hospital , Ottawa, Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avijeet Kumar","family":"Sarker","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology, University of Ottawa , Ottawa, Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology, University of Ottawa , Ottawa, Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Murthy","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology, University of Ottawa , Ottawa, Ontario ,","place":["Canada"]},{"name":"Ottawa Hospital Research Institute, The Ottawa Hospital , Ottawa, Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric I","family":"Benchimol","sequence":"additional","affiliation":[{"name":"SickKids Inflammatory Bowel Disease Centre, Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children (SickKids) , Toronto, Ontario ,","place":["Canada"]},{"name":"Department of Paediatrics and Institute of Health Policy, Management and Evaluation, University of Toronto , Toronto, Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey C","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Toronto , Toronto, Ontario ,","place":["Canada"]},{"name":"Mount Sinai Hospital Centre for Inflammatory Bowel Disease, Division of Gastroenterology , Toronto, Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0658-3062","authenticated-orcid":false,"given":"Jeffrey D","family":"McCurdy","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology, University of Ottawa , Ottawa, Ontario ,","place":["Canada"]},{"name":"Ottawa Hospital Research Institute, The Ottawa Hospital , Ottawa, Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"issue":"4","key":"2025081217441339700_CIT0001","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/ajg.2011.53","article-title":"Venous thromboembolism in inflammatory bowel disease: an epidemiological review","volume":"106","author":"Murthy","year":"2011","journal-title":"Am J Gastroenterol."},{"issue":"1","key":"2025081217441339700_CIT0002","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1572-0241.2006.00943.x","article-title":"Inflammation and coagulation in inflammatory bowel disease: the clot thickens: CME","volume":"102","author":"Danese","year":"2007","journal-title":"Am J Gastroenterol."},{"issue":"6","key":"2025081217441339700_CIT0003","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.cgh.2019.12.043","article-title":"Shedding light on hemostasis in patients with inflammatory bowel diseases","volume":"19","author":"Lagrange","year":"2021","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"3","key":"2025081217441339700_CIT0004","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1055\/s-0037-1615600","article-title":"The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study","volume":"85","author":"Bernstein","year":"2001","journal-title":"Thromb Haemost."},{"issue":"7","key":"2025081217441339700_CIT0005","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1136\/gut.2010.228585","article-title":"Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study","volume":"60","author":"Kappelman","year":"2011","journal-title":"Gut."},{"issue":"9715","key":"2025081217441339700_CIT0006","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(09)61963-2","article-title":"Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study","volume":"375","author":"Grainge","year":"2010","journal-title":"Lancet."},{"issue":"9","key":"2025081217441339700_CIT0007","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1111\/j.1572-0241.2008.02052.x","article-title":"Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients","volume":"103","author":"Nguyen","year":"2008","journal-title":"Am J Gastroenterol."},{"issue":"11","key":"2025081217441339700_CIT0008","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1093\/ibd\/izaa002","article-title":"Risk of venous thromboembolism after hospital discharge in patients with inflammatory bowel disease: a population-based study","volume":"26","author":"McCurdy","year":"2020","journal-title":"Inflamm Bowel Dis."},{"key":"2025081217441339700_CIT0009","doi-asserted-by":"publisher","first-page":"26-32","DOI":"10.1016\/j.thromres.2020.06.005","article-title":"Venous thromboembolic events in inflammatory bowel diseases: a review of current evidence and guidance on risk in the post-hospitalization setting","volume":"194","author":"Murthy","year":"2020","journal-title":"Thromb Res."},{"issue":"12","key":"2025081217441339700_CIT0010","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1111\/apt.15286","article-title":"A clinical predictive model for post-hospitalisation venous thromboembolism in patients with inflammatory bowel disease","volume":"49","author":"McCurdy","year":"2019","journal-title":"Aliment Pharmacol Ther."},{"issue":"3","key":"2025081217441339700_CIT0011","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1053\/j.gastro.2014.01.042","article-title":"Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology","volume":"146","author":"Nguyen","year":"2014","journal-title":"Gastroenterology."},{"issue":"12","key":"2025081217441339700_CIT0012","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/s41575-021-00492-8","article-title":"International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease","volume":"18","author":"Olivera","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"4","key":"2025081217441339700_CIT0013","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1160\/TH16-08-0631","article-title":"Risk assessment models for venous thromboembolism in acutely ill medical patients","volume":"117","author":"Stuck","year":"2017","journal-title":"Thromb Haemost."},{"issue":"9_suppl","key":"2025081217441339700_CIT0014","doi-asserted-by":"publisher","first-page":"127S","DOI":"10.1177\/1076029618797465","article-title":"Risk assessment in Chinese hospitalized patients comparing the Padua and Caprini scoring algorithms","volume":"24","author":"Chen","year":"2018","journal-title":"Clin Appl Thromb Hemost."},{"issue":"4","key":"2025081217441339700_CIT0015","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1160\/TH14-03-0239","article-title":"External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR)","volume":"112","author":"Mahan","year":"2014","journal-title":"Thromb Haemost."},{"key":"2025081217441339700_CIT0016","first-page":"460","article-title":"Scoring systems for estimating risk of venous thromboembolism in hospitalized medical patients","volume-title":"Semin Thromb Hemost","author":"Barbar","year":"2017"},{"issue":"11","key":"2025081217441339700_CIT0017","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/j.cgh.2014.02.034","article-title":"Thromboprophylaxis is associated with reduced post-hospitalization venous thromboembolic events in patients with inflammatory bowel diseases","volume":"12","author":"Ananthakrishnan","year":"2014","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"1","key":"2025081217441339700_CIT0018","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/ecco-jcc\/jjac112","article-title":"Venous thromboembolism following discharge from hospital in patients admitted for inflammatory bowel disease","volume":"17","author":"Harvey","year":"2023","journal-title":"J Crohns Colitis."},{"key":"2025081217441339700_CIT0019","article-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022)","author":"Higgins","year":"2022","journal-title":"Cochrane"},{"issue":"372","key":"2025081217441339700_CIT0020","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"2025081217441339700_CIT0021","doi-asserted-by":"publisher","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann Intern Med."},{"issue":"8","key":"2025081217441339700_CIT0022","doi-asserted-by":"publisher","first-page":"e10047","DOI":"10.7759\/cureus.10047","article-title":"What\u2019s the risk: differentiating risk ratios, odds ratios, and hazard ratios","volume":"12","author":"George","year":"2020","journal-title":"Cureus"},{"key":"2025081217441339700_CIT0023","doi-asserted-by":"publisher","first-page":"106962","DOI":"10.1016\/j.cct.2022.106962","article-title":"Should studies with no events in both arms be excluded in evidence synthesis","volume":"122","author":"Xu","year":"2022","journal-title":"Contemp Clin Trials."},{"issue":"Pt A","key":"2025081217441339700_CIT0024","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cct.2015.09.002","article-title":"Meta-analysis in clinical trials revisited","volume":"45","author":"DerSimonian","year":"2015","journal-title":"Contemp Clin Trials."},{"issue":"12","key":"2025081217441339700_CIT0025","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1007\/s00384-018-3147-y","article-title":"Predication of post-operative outcome of colectomy in ulcerative colitis patients using model of end-stage Liver Disease Score","volume":"33","author":"Lan","year":"2018","journal-title":"Int J Colorectal Dis."},{"issue":"1","key":"2025081217441339700_CIT0026","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1097\/01.MIB.0000480126.53082.70","article-title":"Differences in colitis phenotype and dysplasia among patients with ulcerative colitis with and without primary sclerosing cholangitis","volume":"22","author":"Christophi","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2025081217441339700_CIT0027","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.thromres.2022.09.009","article-title":"Incidence and impact of venous thromboembolism in hospitalized patients with Crohn\u2019s disease","volume":"219","author":"Keller","year":"2022","journal-title":"Thromb Res."},{"issue":"6","key":"2025081217441339700_CIT0028","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1111\/ans.18242","article-title":"Venous thromboembolism risk stratification for patients undergoing surgery for IBD using a novel six factor scoring system using NSQIP-IBD registry","volume":"93","author":"Cheong","year":"2023","journal-title":"ANZ J Surg."},{"issue":"6","key":"2025081217441339700_CIT0029","doi-asserted-by":"publisher","first-page":"S","DOI":"10.1016\/S0016-5085(23)02647-1","article-title":"Su1907 Rising trends of malnutrition with decreasing mortality in patients with inflammatory bowel disease: United States nationwide inpatient sample database 2009-2018","volume":"164","author":"Vohra","year":"2023","journal-title":"Gastroenterology."},{"issue":"5","key":"2025081217441339700_CIT0030","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1053\/j.gastro.2021.06.012","article-title":"Risk of venous thromboembolism among patients with inflammatory bowel disease who contract severe acute respiratory syndrome coronavirus 2","volume":"161","author":"Mahmud","year":"2021","journal-title":"Gastroenterology."},{"issue":"6","key":"2025081217441339700_CIT0031","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(23)02237-0","article-title":"Su1121 biologic therapy prevents covid related complications in inflammatory bowel disease patients","volume":"164","author":"Nanah","year":"2023","journal-title":"Gastroenterology."},{"issue":"4","key":"2025081217441339700_CIT0032","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/jth.13638","article-title":"Inflammatory bowel disease and venous thromboembolism during pregnancy and the postpartum period","volume":"15","author":"Hansen","year":"2017","journal-title":"J Thromb Haemost."},{"issue":"6","key":"2025081217441339700_CIT0033","doi-asserted-by":"publisher","first-page":"e001152","DOI":"10.1161\/JAHA.114.001152","article-title":"External validation of the risk assessment model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for medical patients in a tertiary health system","volume":"3","author":"Rosenberg","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"Suppl 3","key":"2025081217441339700_CIT0034","first-page":"304","article-title":"Clinical assessment of venous thromboembolic risk in surgical patients","volume":"17","author":"Caprini","year":"1991","journal-title":"Semin Thromb Hemost."},{"issue":"3","key":"2025081217441339700_CIT0035","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/jth.12108","article-title":"Venous thromboembolism and the utility of the Padua Prediction Score in patients with sepsis admitted to internal medicine departments","volume":"11","author":"Vardi","year":"2013","journal-title":"J Thromb Haemost."},{"issue":"5","key":"2025081217441339700_CIT0036","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"International Organization for the Study of IBD. STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology."},{"issue":"10114","key":"2025081217441339700_CIT0037","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1016\/S0140-6736(17)32641-7","article-title":"Effect of tight control management on Crohn\u2019s disease (CALM): a multicentre, randomised, controlled phase 3 trial","volume":"390","author":"Colombel","year":"2017","journal-title":"Lancet."},{"issue":"4","key":"2025081217441339700_CIT0038","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1586\/1744666X.2015.1019475","article-title":"The relationship between coagulation state and inflammatory bowel disease: current understanding and clinical implications","volume":"11","author":"Koutroubakis","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"2025081217441339700_CIT0039","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.cgh.2014.07.017","article-title":"Increased risk of venous thromboembolic events with corticosteroid vs biologic therapy for inflammatory bowel disease","volume":"13","author":"Higgins","year":"2015","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"4","key":"2025081217441339700_CIT0040","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/ecco-jcc\/jjx162","article-title":"Steroid but not biological therapy elevates the risk of venous thromboembolic events in inflammatory bowel disease: a meta-analysis","volume":"12","author":"Sarlos","year":"2018","journal-title":"J Crohns Colitis."},{"issue":"2","key":"2025081217441339700_CIT0041","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.thromres.2005.06.006","article-title":"Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers","volume":"118","author":"Brotman","year":"2006","journal-title":"Thromb Res."},{"issue":"11","key":"2025081217441339700_CIT0042","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1002\/ibd.21593","article-title":"Role of tumor necrosis factor-alpha in the extraintestinal thrombosis associated with colonic inflammation","volume":"17","author":"Yoshida","year":"2011","journal-title":"Inflamm Bowel Dis."},{"issue":"4","key":"2025081217441339700_CIT0043","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.4049\/jimmunol.176.4.2617","article-title":"TNF-alpha blockade down-regulates the CD40\/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn\u2019s disease","volume":"176","author":"Danese","year":"2006","journal-title":"J Immunol."},{"issue":"2","key":"2025081217441339700_CIT0044","doi-asserted-by":"publisher","first-page":"e002571","DOI":"10.1136\/rmdopen-2022-002571","article-title":"Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors","volume":"8","author":"Weitz","year":"2022","journal-title":"RMD Open."},{"issue":"6","key":"2025081217441339700_CIT0045","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.semarthrit.2021.10.001","article-title":"Risk of venous thromboembolism associated with methotrexate versus hydroxychloroquine for rheumatoid arthritis: a propensity score-matched cohort study","volume":"51","author":"He","year":"2021","journal-title":"Semin Arthritis Rheum."},{"issue":"17","key":"2025081217441339700_CIT0046","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.3748\/wjg.v20.i17.4857","article-title":"Venous thrombosis and prothrombotic factors in inflammatory bowel disease","volume":"20","author":"Magro","year":"2014","journal-title":"World J Gastroenterol."},{"issue":"3","key":"2025081217441339700_CIT0047","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/ecco-jcc\/jjv213","article-title":"The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease","volume":"10","author":"Harbord","year":"2016","journal-title":"J Crohns Colitis."},{"issue":"1","key":"2025081217441339700_CIT0048","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/DCR.0000000000000982","article-title":"The American Society of Colon and Rectal Surgeons clinical practice guideline for the prevention of venous thromboembolic disease in colorectal surgery","volume":"61","author":"Fleming","year":"2018","journal-title":"Dis Colon Rectum."},{"issue":"10","key":"2025081217441339700_CIT0049","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1097\/DCR.0000000000001189","article-title":"Extended venous thromboembolism prophylaxis after elective surgery for IBD patients: nomogram-based risk assessment and prediction from nationwide cohort","volume":"61","author":"Benlice","year":"2018","journal-title":"Dis Colon Rectum."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/8\/2286\/63142598\/izaf078.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/8\/2286\/63142598\/izaf078.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T21:44:18Z","timestamp":1755035058000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/31\/8\/2286\/8128506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":49,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,5,9]]},"published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izaf078","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,5,9]]}}}